Type and hit ENTER

RESEARCH AND DEVELOPMENT

Research and Development

ProAxsis are actively looking for co-development partners or collaborative projects in the field of protease biomarkers, target and compound validation.

Specialist Services

Bespoke Assay Development
Peptide-based inhibitor design and synthesis
Enzyme kinetics and compound characterisation
Activity-based steady state assays
SDS-PAGE and western blotting
ELISAs
Activity-based Immunoassays

ProAxsis

Follow Me

RT @pharmacyatQUB: We'll be celebrating our students' successes this evening at our Undergraduate Awards Ceremony. Thanks to our sponsors:…

9 hours ago

- ProAxsis

RT @drAnand_Shah_: @Shoemelia presenting evidence for point of care neutrophil elastase use in #bronchiectasis #ERSCongress2019 https://t.c…

12 days ago

- ProAxsis

RT @BlfResearch: Further studies are needed to assess how widely NEATstik could be used in clinical practice, but it can help tackle the mi…

12 days ago

- ProAxsis

RT @BlfResearch: What does it mean for patients? At the moment, it takes several days to carry out tests to confirm a chest infection. This…

12 days ago

- ProAxsis

RESEARCH AND DEVELOPMENT | ProAxsis

RESEARCH AND DEVELOPMENT

Research and Development

Specialist Services

New data demonstrates high potential of NEATstik® as a rapid point-of-care monitoring tool for lung diseases

ProAxsis to present data on novel immunoassay at 2018 British Thoracic Society Winter Meeting

ProAxsis assays selected for inclusion in major new ERS-funded study